Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy.

Aronica E, Zurolo E, Iyer A, de Groot M, Anink J, Carbonell C, van Vliet EA, Baayen JC, Boison D, Gorter JA.

Epilepsia. 2011 Sep;52(9):1645-55. doi: 10.1111/j.1528-1167.2011.03115.x. Epub 2011 Jun 2.

2.

The adenosine kinase hypothesis of epileptogenesis.

Boison D.

Prog Neurobiol. 2008 Mar;84(3):249-62. doi: 10.1016/j.pneurobio.2007.12.002. Epub 2007 Dec 23. Review.

3.

Adenosine dysfunction in epilepsy.

Boison D.

Glia. 2012 Aug;60(8):1234-43. doi: 10.1002/glia.22285. Epub 2011 Dec 22. Review.

4.

Role of adenosine in status epilepticus: a potential new target?

Boison D.

Epilepsia. 2013 Sep;54 Suppl 6:20-2. doi: 10.1111/epi.12268. Review.

5.

Molecular neuropathology of temporal lobe epilepsy: complementary approaches in animal models and human disease tissue.

Majores M, Schoch S, Lie A, Becker AJ.

Epilepsia. 2007;48 Suppl 2:4-12. Review.

PMID:
17571348
6.

Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Aronica E, Sandau US, Iyer A, Boison D.

Neurochem Int. 2013 Dec;63(7):688-95. doi: 10.1016/j.neuint.2013.01.028. Epub 2013 Feb 4. Review.

7.

Glutamate and astrocytes--key players in human mesial temporal lobe epilepsy?

Eid T, Williamson A, Lee TS, Petroff OA, de Lanerolle NC.

Epilepsia. 2008;49 Suppl 2:42-52. doi: 10.1111/j.1528-1167.2008.01492.x. Review.

8.

Role of the purinergic signaling in epilepsy.

Cieślak M, Wojtczak A, Komoszyński M.

Pharmacol Rep. 2017 Feb;69(1):130-138. doi: 10.1016/j.pharep.2016.09.018. Epub 2016 Sep 22. Review.

PMID:
27915186
9.

Altered structure and function of astrocytes following status epilepticus.

Wilcox KS, Gee JM, Gibbons MB, Tvrdik P, White JA.

Epilepsy Behav. 2015 Aug;49:17-9. doi: 10.1016/j.yebeh.2015.05.002. Epub 2015 Jul 26. Review.

10.

Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.

Boison D, Stewart KA.

Biochem Pharmacol. 2009 Dec 15;78(12):1428-37. doi: 10.1016/j.bcp.2009.08.005. Epub 2009 Aug 12. Review.

11.

Comorbidities in Neurology: Is adenosine the common link?

Boison D, Aronica E.

Neuropharmacology. 2015 Oct;97:18-34. doi: 10.1016/j.neuropharm.2015.04.031. Epub 2015 May 13. Review.

12.

Adenosine kinase: exploitation for therapeutic gain.

Boison D.

Pharmacol Rev. 2013 Apr 16;65(3):906-43. doi: 10.1124/pr.112.006361. Print 2013 Jul. Review.

13.

Inhibitory RNA in epilepsy: research tools and therapeutic perspectives.

Boison D.

Epilepsia. 2010 Sep;51(9):1659-68. doi: 10.1111/j.1528-1167.2010.02672.x. Epub 2010 Jul 15. Review.

14.

Adenosine Augmentation Therapy.

Boison D.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

15.

Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.

Hadera MG, McDonald T, Smeland OB, Meisingset TW, Eloqayli H, Jaradat S, Borges K, Sonnewald U.

Neurochem Res. 2016 Feb;41(1-2):86-95. doi: 10.1007/s11064-015-1728-5. Epub 2015 Oct 3. Review.

PMID:
26433381
16.

MicroRNA regulation and dysregulation in epilepsy.

Dogini DB, Avansini SH, Vieira AS, Lopes-Cendes I.

Front Cell Neurosci. 2013 Oct 4;7:172. doi: 10.3389/fncel.2013.00172. Review.

17.

Neural Stem Cell Therapy for Temporal Lobe Epilepsy.

Shetty AK.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

Supplemental Content

Support Center